Variables | Progression Group (n = 198) | Non-progression Group (n = 168) | p value |
---|---|---|---|
Age | 65.83 ± 11.46 | 64.74 ± 10.19 | 0.375 |
Sex(Man/Women) | 158/40 | 139/29 | 0.474 |
BMI (kg/m2) | 25.47 ± 3.18 | 24.80 ± 3.63 | 0.421 |
Hypertension (%) | 153 (77.3) | 121 (72.5) | 0.289 |
Diabetes (%) | 85 (42.9) | 51 (30.4) | 0.013 |
NGR (%) | 67 (33.8) | 86 (51.2) | 0.001 |
IFG (%) | 13 (6.6) | 7 (4.2) | 0.362 |
IGT (%) | 20 (10.1) | 18 (10.8) | 0.865 |
IFG + IGT (%) | 13 (6.6) | 6 (3.6) | 0.241 |
Initial admission n (%) | Â | Â | Â |
ECG abnormalities | 24 (12.1) | 12 (7.1) | 0.111 |
Stable Angina | 29 (14.6) | 33 (19.6) | 0.204 |
Unstable Angina | 86 (43.4) | 70 (41.7) | 0.733 |
Non-ST elevated AMI | 10(5.1) | 9(5.4) | 0.895 |
ST elevated AMI | 49 (24.7) | 44 (26.2) | 0.752 |
Medication (%) | Â | Â | Â |
Statin | 196 (99.5) | 165 (98.8) | 0.468 |
CCB | 67(29.6) | 55(32.9) | 0.806 |
ACEI/ARB | 104 (53.6) | 76 (46.1) | 0.154 |
β-blocker | 164 (82.8) | 128(76.6) | 0.141 |
Oral glucose lowering dug | 70(35.9) | 35(21.2) | 0.002 |
Application of insulin | 9(4.5) | 11(6.5) | 0.491 |